SUTRO BIOPHARMA, INC.·4

Jul 13, 6:40 PM ET

Vasquez Nicki 4

4 · SUTRO BIOPHARMA, INC. · Filed Jul 13, 2023

Insider Transaction Report

Form 4
Period: 2023-07-12
Vasquez Nicki
Chief Port. Strat & Alnce Ofcr
Transactions
  • Exercise/Conversion

    Common Stock

    2023-07-12+3,25026,111 total
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2023-07-123,2506,500 total
    Exp: 2025-07-12Common Stock (3,250 underlying)
  • Tax Payment

    Common Stock

    2023-07-12$4.70/sh1,123$5,27824,988 total
Footnotes (3)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
  • [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F3]The RSUs vest as to 1/4th of the total shares annually beginning on July 12, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION